Advancing Research Through the Global Biobank 

The Ehlers-Danlos Society is developing an Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD) Biobank, thanks to a generous $2.5 million donation. Part of an overall $6.7 million donation to research from the Mike and Sofia Segal Foundation, this biobank represents a significant advancement for researchers studying Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD). 

What is the biobank? 

The biobank is made up of two key parts. The first is secure storage of biological samples such as blood, tissues like skin and muscle, and urine from each person participating in the biobank. From these samples, it is possible to extract things like genetic material, and proteins for research. The second part is the collection of information about each participant. This includes things like their age, gender, ethnicity, diagnosis, health concerns, and lifestyle. 

The samples will come from people diagnosed with a type of EDS or HSD, people who have chronic pain and fatigue syndromes but who do not have EDS or HSD, and from people who are healthy. By collecting information from these other groups researchers can compare findings with EDS or HSD. These other groups are called “controls” in case-control studies. This helps researchers identify whether their findings are general ones or apply specifically to EDS or HSD.  

What will the biobank be used for? 

The biobank will be a crucial resource for learning more about the types of EDS and HSD. It will help researchers study these conditions to find better ways to diagnose, treat, and care for people with them. By giving scientists access to a variety of biological samples and information about people’s health concerns, it lets them dig deeply into what causes these conditions and how to help people who have them. 

How will the biobank help research? 

The biobank will advance medical research by providing scientists with samples that they can use to better understand EDS and HSD at a genetic, protein, and tissue level. This can help researchers find new treatments for these conditions. 

Research can help us in: 

  • Supporting Biomarker Discovery: Biomarkers are molecules that signal normal or abnormal bodily processes. Identifying biomarkers for EDS and HSD could eventually help doctors diagnose these conditions earlier, assess a person’s risk to specific symptoms, and monitor their response to therapies. 
  • Understanding Disease Progression: By looking at samples collected over time, researchers can see how these conditions change and what factors might make them worse or better. 
  • Facilitating Drug Development and Clinical Trials: Having access to many samples helps speed up the process of finding and testing new treatments for EDS and HSD. 
  • Personalized Medicine: Findings from the biobank research can be used to advance personalized medicine, which is the individualizing of treatment to the unique characteristics of each person.
  • Fostering Collaboration and Data Sharing: The biobank will bring researchers together from all over the world to share what they find, helping everyone work together to solve these medical puzzles faster.

Participate in the EDS and HSD Biobank Research Study – November 11–14, 2025 | Philadelphia, PA, USA

We invite you to learn more about an opportunity to participate in biobank research taking place in Philadelphia, PA, this November.

As part of The Ehlers-Danlos Society’s Global EDS and HSD Biobank, we are collecting biological samples and health information from individuals with different health backgrounds to support vital research into Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD).

What Is Involved?

If you are eligible, participation includes:

  • A brief health and lifestyle questionnaire
  • One-time donation of biological samples (such as blood, saliva, and/or urine)

Who Can Take Part?

We are looking for individuals from three groups:

  • People diagnosed with a type of EDS or HSD
  • People with chronic pain and/or fatigue syndromes who do not have EDS or HSD
  • Healthy individuals without these conditions

Including a broad range of participants allows researchers to compare findings across different populations and gain a clearer understanding of EDS and HSD.

Event Details:

  • Dates: November 11-14, 2025
  • Location: Wyndham Philadelphia Historic District, 400 Arch Street, Philadelphia, PA 19106

Why Participate?

Your participation may help researchers better understand EDS and HSD at the genetic, protein, and tissue level. The information collected may support:

  • Earlier and more accurate diagnosis
  • Better understanding of symptom progression
  • Development of new treatments
  • Advancements in personalized medicine

Participation is voluntary, and your information will be kept secure and confidential.

How to Participate

Appointment spaces are now full. Please subscribe to our Newsletter for updates on future events.

FAQs

  • What is the EDS and HSD Biobank?

    The Ehlers-Danlos Society’s Global EDS and HSD Biobank is a research initiative collecting biological samples and health information from individuals with a variety of health backgrounds. The biobank supports research into Ehlers-Danlos syndromes (EDS), hypermobility spectrum disorders (HSD), and related conditions.

  • What types of samples will be collected?

    If you are eligible and choose to participate, the study may involve donating:

    • Blood
    • Saliva
    • Urine

    Samples are used for future research to help better understand EDS and HSD at a genetic, tissue, and molecular level.

  • Do I have to give all of the samples?

    No. Participation is voluntary, and you are not required to provide all types of samples. You can discuss your preferences with the research team. For example, you may choose to give a urine sample but not blood or skin.

  • Who can take part in the study?

    The study is open to people in three groups:

    • Individuals diagnosed with a type of EDS or HSD
    • Individuals with chronic pain and/or fatigue syndromes without an EDS or HSD diagnosis
    • Healthy individuals with no history of these conditions

    Including a variety of participants allows researchers to compare findings and study how EDS and HSD may differ from other conditions or from general health.

  • Where is the event taking place?

    • Location: Philadelphia, PA, USA
    • Dates: November 11–14, 2025

    Eligible participants will be scheduled for a one-time appointment during this time frame.

  • What will I need to do if I participate?

    If you are eligible, participation includes:

    • Completing a brief health and lifestyle questionnaire
    • Donating one or more biological samples (depending on your comfort and eligibility)

    A member of the research team will review everything with you before any samples are collected.

  • How do I sign up or get more information?

    If you’re interested, please complete the interest form here, and a research team member will contact you with more details about eligibility and next steps.

  • Is my personal information secure?

    Yes. All health and personal information you provide will be kept secure and confidential in accordance with ethical research standards and data protection policies.

  • Will this help me get a diagnosis or treatment?

    No. This is a research study, not a clinical or diagnostic service. While the study may contribute to future advances in diagnosis or treatment, it is not intended to provide individual medical care or advice.

  • Where can I ask questions about the event?

    Please email questions to [email protected].

  • This event is too far from me, but I still want to participate. What can I do?

    We understand that travel distance can be a challenge. If you are unable to attend Philadelphia, please keep an eye on our website and social media channels for announcements of future recruitment events in other regions.

    At this time, participation requires attending an in-person event because biological samples need to be collected under research governance standards. We are exploring ways to expand participation opportunities over time.

  • Why have you chosen Philadelphia for this event?

    We selected Philadelphia after reviewing data from our DICE Global Registry and our website traffic analytics, which highlighted areas where many of our community members are located. Philadelphia was identified as a key location “hotspot” and offers suitable clinical and logistical facilities for safely carrying out study procedures in compliance with Good Clinical Practice (GCP).

    We plan to host future events in other locations, both in the U.S. and internationally, to make participation easier for as many people as possible.

  • What to Expect at a Global Biobank Recruitment Visit

    Your visit will last approximately 90 minutes, if you register your interest a member of our team will be in touch with you to provide you a link that allows you to book an appointment slot. Slots are available from 8:30 am- 4:30 pm.

  • I’ve received a booking link but can’t find an appointment time that works for me. What should I do?

    If you are unable to find an available appointment time, it is likely that all current slots are full. Appointment numbers are limited to ensure that each participant receives adequate time and attention from the study team.

    Please do not travel to the event without a confirmed appointment, as we can only see participants who have scheduled time slots.

    Appointment availability may change if others who have already booked need to cancel or reschedule, so we recommend checking back periodically to see if a suitable time becomes available.

Sign up to The Ehlers-Danlos Society mailing list